Quantum Monte Carlo and perturbative study of two-dimensional Bose-Fermi mixtures
Physical Review A · 02.05.2024 · 109 (5)
DOI: 10.1103/physreva.109.053302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review A, online erschienen am 02.05.2024. Verfasst von Jacopo D'Alberto und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Italian Ministry of University and Research.
Abstract (Originalsprache)
We derive analytically the leading beyond-mean field contributions to the zero-temperature equation of state and to the fermionic quasi-particle residue and effective mass of a dilute Bose-Fermi mixture in two dimensions. In the repulsive case, we perform quantum Monte Carlo simulations for two representative bosonic concentrations and equal masses, extending a method for correcting finite-size effects in fermionic gases to Bose-Fermi mixtures. We find good agreement between analytic expressions and numerical results for weak interactions, while significant discrepancies appear in the regime close to mechanical instability, above which we provide evidence of phase separation of the bosonic component.
Förderung
- Italian Ministry of University and Research
Zitieren
APA
D'Alberto, J., Cardarelli, L., Galli, D. E., Bertaina, G., & Pieri, P. (2024). Quantum Monte Carlo and perturbative study of two-dimensional Bose-Fermi mixtures. Physical Review A, 109(5). https://doi.org/10.1103/physreva.109.053302
Vancouver
D'Alberto J, Cardarelli L, Galli DE, Bertaina G, Pieri P. Quantum Monte Carlo and perturbative study of two-dimensional Bose-Fermi mixtures. Physical Review A. 2024;109(5). doi:10.1103/physreva.109.053302
BibTeX
@article{DAlberto2024,
author = {D'Alberto, Jacopo and Cardarelli, Lorenzo and Galli, Davide Emilio and Bertaina, Gianluca and Pieri, Pierbiagio},
title = {Quantum Monte Carlo and perturbative study of two-dimensional Bose-Fermi mixtures},
journal = {Physical Review A},
year = {2024},
volume = {109},
number = {5},
doi = {10.1103/physreva.109.053302}
}
EUVIMED